Healthcare -
Drug Manufacturers - Specialty & Generic - NASDAQ - CA
$ 1.28
7.56 %
$ 266 M
Market Cap
-0.31
P/E
1. INTRINSIC VALUE
FINANCIALS
Balance Sheet
Canopy Growth Corporation
| Current Assets | 293 M |
| Cash & Short-Term Investments | 137 M |
| Receivables | 52.5 M |
| Other Current Assets | 103 M |
| Non-Current Assets | 620 M |
| Long-Term Investments | 179 M |
| PP&E | 292 M |
| Other Non-Current Assets | 149 M |
| Current Liabilities | 93.9 M |
| Accounts Payable | 25.9 M |
| Short-Term Debt | 20.7 M |
| Other Current Liabilities | 47.2 M |
| Non-Current Liabilities | 334 M |
| Long-Term Debt | 326 M |
| Other Non-Current Liabilities | 8.44 M |
EFFICIENCY
Earnings Waterfall
Canopy Growth Corporation
| Revenue | 267 M |
| Cost Of Revenue | 212 M |
| Gross Profit | 55 M |
| Operating Expenses | 121 M |
| Operating Income | -66 M |
| Other Expenses | 535 M |
| Net Income | -601 M |
RATIOS
FREE CASH FLOW ANALYSIS
Free Cash Flow Analysis
Canopy Growth Corporation
| Net Income | -601 M |
| Depreciation & Amortization | 42.9 M |
| Capital Expenditures | -10.8 M |
| Stock-Based Compensation | -4.2 M |
| Change in Working Capital | -41.1 M |
| Others | 428 M |
| Free Cash Flow | -177 M |
Wall Street Analysts Price Targets
Canopy Growth Corporation
Wall Street analysts predict an average 1-year price target for CGC of $17.7 , with forecasts ranging from
a
low of
$8 to a high of $35 .
CGC Lowest Price Target
Wall Street Target
8 USD
525.00%
CGC Average Price Target
Wall Street Target
17.7 USD
1280.86%
CGC Highest Price Target
Wall Street Target
35 USD
2634.38%
4. DIVIDEND
ANALYSIS
CGC does not distribute dividends.
5. COMPETITION
6. Ownership
Insider Ownership
Canopy Growth Corporation
Sold
0-3 MONTHS
122 K USD 5
3-6 MONTHS
6.46 K USD 3
6-9 MONTHS
24.1 K USD 4
9-12 MONTHS
939 K USD 7
Bought
0 USD 0
0-3 MONTHS
0 USD 0
3-6 MONTHS
0 USD 0
6-9 MONTHS
0 USD 0
9-12 MONTHS
7. News
Americans Should Buy Canadian Cannabis Companies
Canadian LPs offer compelling risk/reward versus U.S. cannabis stocks, with stronger balance sheets, tangible book value, and global opportunities due to federal legality. Despite recent rallies, Canadian LPs remain cheap on enterprise value to EBITDA, especially Village Farms, Organigram, and Tilray Brands, which I hold in my model portfolio. U.S. MSOs face significant risks from 280E tax liabilities and negative tangible equity, making Canadian LPs a safer bet for cannabis investors right now.
seekingalpha.com
- 1 week ago
Canopy Growth Corporation (CGC) Is a Trending Stock: Facts to Know Before Betting on It
Zacks.com users have recently been watching Canopy Growth (CGC) quite a bit. Thus, it is worth knowing the facts that could determine the stock's prospects.
zacks.com
- 1 week ago
Canadian Gold Corp. Closes Over-Subscribed Private Placement for New Hammond Reef South Program
Flin Flon, Manitoba--(Newsfile Corp. - June 30, 2025) - Canadian Gold Corp. (TSXV: CGC) ("Canadian Gold" or the "Company") is pleased to announce that it has closed its non-brokered private placement (the "Offering") previously announced on June 19, 2025. The Company issued a total of 1,203,125 flow-through common shares, at a price of $0.32 per share, for gross proceeds of $385,000.
newsfilecorp.com
- 1 week ago
Canopy Growth Corporation (CGC) Stock Declines While Market Improves: Some Information for Investors
Canopy Growth Corporation (CGC) closed at $1.22 in the latest trading session, marking a -1.61% move from the prior day.
zacks.com
- 2 weeks ago
Here Is A List Of 3 Canadian Marijuana Stocks To Watch 2025
The outlook for investing in marijuana stocks has changed for many. The sector is facing continuous dips and a serious lack of upward momentum. This has left many wondering what to do and how to take action to recoup their investment. It seems that, if not almost all, shareholders share the same fate. Shareholders will have to either cut their losses or continue to be patient till there is a change in the market.
marijuanastocks.com
- 2 weeks ago
Canopy Growth Corporation (CGC) Stock Declines While Market Improves: Some Information for Investors
In the closing of the recent trading day, Canopy Growth Corporation (CGC) stood at $1.19, denoting a -4.03% move from the preceding trading day.
zacks.com
- 2 weeks ago
Canopy Growth Corporation (CGC) is Attracting Investor Attention: Here is What You Should Know
Canopy Growth (CGC) has been one of the stocks most watched by Zacks.com users lately. So, it is worth exploring what lies ahead for the stock.
zacks.com
- 3 weeks ago
Canadian Gold Corp. Private Placement Offering for New Hammond Reef South Program to Follow up 2024 Surface Samples That Returned 35.4 g/t Gold
Flin Flon, Manitoba--(Newsfile Corp. - June 19, 2025) - Canadian Gold Corp. (TSXV: CGC) ("Canadian Gold" or the "Company") is pleased to announce plans for a follow-up program on the discovery of the new high-grade zone (announced August 6, 2024), that returned 35.4 g/t and 7.1 g/t gold from surface samples at the Company's 100%-held Hammond Reef South property, located near Atikokan, Ontario. The Company's properties are adjacent to Agnico Eagle's fully permitted Hammond Reef Project, which contains a mineral resource of more than 5 million ounces of gold and occurs in the same geological environment (Fig.
newsfilecorp.com
- 3 weeks ago
3 Canadian Cannabis Stocks Traders Are Watching Closely This Week
Top Canadian cannabis stocks are gaining fresh attention as U.S. markets show signs of acceleration. The U.S. cannabis industry is projected to reach $45 billion by 2025. Furthermore, analysts expect it to grow past $75 billion before 2030. This momentum is driven by rising consumer demand and favorable legislative trends. Recently, federal policymakers have signaled potential changes to cannabis scheduling.
marijuanastocks.com
- 3 weeks ago
Canopy Growth Corporation (CGC) Stock Drops Despite Market Gains: Important Facts to Note
In the closing of the recent trading day, Canopy Growth Corporation (CGC) stood at $1.45, denoting a -2.03% move from the preceding trading day.
zacks.com
- 3 weeks ago
1 Beaten-Down Stock Down 99% That's Still Not Worth Buying
Canopy Growth (CGC -2.61%) emerged as a leader in the cannabis industry when Canada legalized recreational, adult use of the substance in 2018. Investors had high hopes for the company and the rest of the market but, unfortunately, these hopes have now evaporated.
fool.com
- 4 weeks ago
Cannabis Stock CGC Rallies 39% in Three Months: Time to Buy or Sell?
Canopy Growth surges 39% in three months as restructuring, margin gains and debt cuts renew investor interest.
zacks.com
- 1 month ago
8. Profile
Summary
Canopy Growth Corporation CGC
COUNTRY
CA
INDUSTRY
Drug Manufacturers - Specialty & Generic
MARKET CAP
$ 266 M
Dividend Yield
0.00%
Description
Canopy Growth Corporation, together with its subsidiaries, engages in the production, distribution, and sale of cannabis and hemp-based products for recreational and medical purposes primarily in Canada, the United States, and Germany. It operates through two segments, Global Cannabis and Other Consumer Products. The company's products include dried cannabis flower, extracts and concentrates, beverages, gummies, and vapes. It offers its products under the Tweed, 7ACRES, 7ACRES Craft Collective, DOJA, Ace Valley, Quatreau, Deep Space, First + Free, Surity Pro, Spectrum Therapeutics, Vert, Tokyo Smoke, Twd, Martha Stewart CBD, DNA Genetics, BioSteel, Storz & Bickel, This Works, HiWay, Simple Stash, Whisl, and Truverra brands. The company was formerly known as Tweed Marijuana Inc. and changed its name to Canopy Growth Corporation in September 2015. Canopy Growth Corporation was incorporated in 2009 and is headquartered in Smiths Falls, Canada.
Contact
1 Hershey Drive, Smiths Falls, ON, K7A 0A8
https://www.canopygrowth.com
IPO
Date
April 7, 2014
Employees
1029
Officers
Jason Green
Head of Agriculture - Hemp Division
Mr. Andrew Bevan
Senior Vice President of Medical Sales
Mr. Jurgen Bickel
MD and Co-Founder of STORZ & BICKEL GmbH
Ms. Jenny Brewer
Chief Human Resources Officer
Mr. Luc Mongeau
Chief Executive Officer & Director
Dr. Christelle Gedeon L.L.B., Ph.D.
Chief Legal Officer & Corporate Secretary
Mr. Dave Paterson
President of Canadian Recreational Cannabis
Mr. Bryan Murphy
Senior Vice President of Operations
Mr. Tyler Burns
Director of Investor Relations
Ms. Judy Eunjoo Hong
Chief Financial Officer & Principal Accounting Officer